| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 93229 |
|
6,714 |
6,704 |
$4.22M |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
24,801 |
20,822 |
$3.07M |
| 36475 |
|
2,017 |
1,791 |
$2.70M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
38,920 |
37,441 |
$2.68M |
| 93351 |
|
8,750 |
8,736 |
$1.64M |
| 36478 |
|
788 |
738 |
$1.06M |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
9,390 |
9,380 |
$918K |
| 36465 |
|
654 |
592 |
$858K |
| 93970 |
|
6,259 |
6,228 |
$800K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
11,287 |
10,922 |
$442K |
| 93320 |
|
8,558 |
8,543 |
$421K |
| 93971 |
|
5,304 |
4,735 |
$407K |
| 93000 |
|
22,065 |
21,976 |
$365K |
| 93325 |
|
8,566 |
8,549 |
$336K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
1,724 |
1,550 |
$330K |
| 76706 |
|
5,071 |
5,042 |
$315K |
| 93880 |
|
2,262 |
2,260 |
$251K |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
9,478 |
4,900 |
$244K |
| 93356 |
|
8,319 |
8,108 |
$241K |
| 93228 |
|
6,663 |
6,649 |
$170K |
| 93224 |
|
1,897 |
1,895 |
$150K |
| 99454 |
|
2,621 |
2,616 |
$123K |
| A9505 |
Thallium tl-201 thallous chloride, diagnostic, per millicurie |
1,098 |
1,093 |
$103K |
| 99457 |
|
2,976 |
2,969 |
$100K |
| 93925 |
|
851 |
850 |
$98K |
| 93015 |
|
1,377 |
1,369 |
$80K |
| 36466 |
|
56 |
50 |
$77K |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
826 |
822 |
$65K |
| 99458 |
|
2,118 |
2,116 |
$61K |
| J2785 |
Injection, regadenoson, 0.1 mg |
360 |
360 |
$57K |
| 93922 |
|
976 |
966 |
$48K |
| 99215 |
Prolong outpt/office vis |
268 |
258 |
$37K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,710 |
1,692 |
$31K |
| 93298 |
|
1,103 |
1,101 |
$31K |
| 94690 |
|
883 |
882 |
$28K |
| G2066 |
Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results |
1,149 |
1,148 |
$26K |
| 76775 |
|
492 |
490 |
$24K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
827 |
822 |
$24K |
| 93297 |
|
1,437 |
1,432 |
$23K |
| 99205 |
Prolong outpt/office vis |
101 |
99 |
$18K |
| 99453 |
|
942 |
919 |
$15K |
| 93319 |
|
311 |
297 |
$12K |
| 99406 |
|
769 |
764 |
$8K |
| 93296 |
|
194 |
194 |
$5K |
| 99490 |
Ccm add 20min |
828 |
828 |
$4K |
| 93295 |
|
82 |
82 |
$3K |
| 93291 |
|
94 |
94 |
$3K |
| J7050 |
Infusion, normal saline solution, 250 cc |
1,131 |
1,130 |
$2K |
| 93294 |
|
117 |
117 |
$2K |
| 96127 |
|
447 |
442 |
$2K |
| 93280 |
|
28 |
28 |
$2K |
| A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose |
12 |
12 |
$1K |
| J0153 |
Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) |
533 |
521 |
$1K |
| 94621 |
|
14 |
14 |
$1K |
| 93975 |
|
12 |
12 |
$1K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
29 |
28 |
$977.05 |
| 95923 |
|
44 |
44 |
$871.36 |
| 99407 |
|
38 |
38 |
$780.58 |
| 93290 |
|
27 |
27 |
$725.60 |
| 93244 |
|
33 |
33 |
$636.18 |
| 99439 |
|
249 |
249 |
$563.51 |
| 93242 |
|
34 |
34 |
$447.74 |
| 99152 |
|
15 |
14 |
$335.13 |
| 93227 |
|
24 |
24 |
$316.70 |
| 93225 |
|
13 |
13 |
$224.41 |
| 95921 |
|
12 |
12 |
$19.71 |